New drug ‘functionally cures’ many hepatitis B virus infections GSK’s “bepi” performs better than expected in efficacy trials, but its global impact is likely limited. (Science, 28.05.2026) https://www.science.org/content/article/new-drug-function…

Gender differences in hepatitis C virus incidence in and out of opioid agonist treatment among people who inject drugs in Montréal, Canada, March 2011-March 2024 Meconnen M, Kleiner BB, Artenie A, Bruneau J, Azar M, Minoyan N, Zang G, Martel-Laferr…

Strategien der Hepatitis-C-Elimination Menschen mit injizierendem Drogenkonsum sind die primäre Zielgruppe Auf der To-Do-Liste der WHO steht im Rahmen der Nachhaltigkeitsziele (SDGs) die Elimination der Hepatitis C (HCV): Ausgehend vom Jahr 2015 s…

WHO. Efforts to eliminate hepatitis delivers gains but more action needed to meet 2030 targets Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global hea…

Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.  Conway A, Grebely J, Tillakeratne S, Cunningham EB, Munyengeterwa U, Van Dyk J, Martinel…

Maternal opioid use and hepatitis C infection disrupt the placental immune landscape and structure.  True HE, Doratt BM, Wagner SB, Malherbe DC, Shelman NR, Eskandarian Boroujeni M, Cockerham C, O'Brien JM, Messaoudi I.  JCI Insight. 202…